Barrington raised the firm’s price target on Adtalem Global Education to $70 from $65 and keeps an Outperform rating on the shares following the fiscal Q3 beat. The firm expects demand for healthcare professionals, which represents approximately 90% of Adtalem’s enrollment, will continue to outpace supply for the foreseeable future.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ATGE: